Search research articles
Contact Us
Filters
Showing results (151-160 of 161) with videos related to
Page
of 17
Sort By:
Cancer
|
January 17, 2018
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma
Eileen M O'Reilly, Jonathan W Lee, Maeve A Lowery, et al.
Biorxiv : the Preprint Server for Biology
|
April 16, 2025
Aging-dependent dysregulation of EXOSC2 is maintained in cancer as a dependency
Maria Skamagki, Cheng Zhang, Ezgi Hacisuleyman, et al.
The Oncologist
|
October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer
Ryan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 16, 2025
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms
Rohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Journal of the National Cancer Institute
|
September 12, 2023
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
Melissa A Lumish, Henry Walch, Steven B Maron, et al.
JCO Precision Oncology
|
November 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms
Rohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 24, 2020
Validation of a digital pathology system including remote review during the COVID-19 pandemic
Matthew G Hanna, Victor E Reuter, Orly Ardon, et al.
Annals of Surgery
|
October 1, 2019
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors
Alessandra Pulvirenti, Ammar A Javed, Luca Landoni, et al.
The Lancet. Oncology
|
September 4, 2023
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial
Samuel L Cytryn, Ryan H Moy, Darren Cowzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2024
<i>TERT</i> Expression and Clinical Outcome in Pulmonary Carcinoids
Lisa Werr, Christoph Bartenhagen, Carolina Rosswog, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 161) with videos related to
Sort By:
Page
of 17
Cancer
|
January 17, 2018
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma
Eileen M O'Reilly, Jonathan W Lee, Maeve A Lowery, et al.
Biorxiv : the Preprint Server for Biology
|
April 16, 2025
Aging-dependent dysregulation of EXOSC2 is maintained in cancer as a dependency
Maria Skamagki, Cheng Zhang, Ezgi Hacisuleyman, et al.
The Oncologist
|
October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer
Ryan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 16, 2025
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms
Rohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Journal of the National Cancer Institute
|
September 12, 2023
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
Melissa A Lumish, Henry Walch, Steven B Maron, et al.
JCO Precision Oncology
|
November 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms
Rohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 24, 2020
Validation of a digital pathology system including remote review during the COVID-19 pandemic
Matthew G Hanna, Victor E Reuter, Orly Ardon, et al.
Annals of Surgery
|
October 1, 2019
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors
Alessandra Pulvirenti, Ammar A Javed, Luca Landoni, et al.
The Lancet. Oncology
|
September 4, 2023
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial
Samuel L Cytryn, Ryan H Moy, Darren Cowzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2024
<i>TERT</i> Expression and Clinical Outcome in Pulmonary Carcinoids
Lisa Werr, Christoph Bartenhagen, Carolina Rosswog, et al.
Page
of 17